UniProt ID | OPTN_MOUSE | |
---|---|---|
UniProt AC | Q8K3K8 | |
Protein Name | Optineurin | |
Gene Name | Optn | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 584 | |
Subcellular Localization | Cytoplasm, perinuclear region . Golgi apparatus . Golgi apparatus, trans-Golgi network. Cytoplasmic vesicle, autophagosome. Cytoplasmic vesicle. Recycling endosome. Found in the perinuclear region and associates with the Golgi apparatus. Colocalizes | |
Protein Description | Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8. Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation. Plays a role in the activation of innate immune response during viral infection. Mechanistically, recruits TBK1 at the Golgi apparatus, promoting its trans-phosphorylation after RLR or TLR3 stimulation. In turn, activated TBK1 phosphorylates its downstream partner IRF3 to produce IFN-beta. Plays a neuroprotective role in the eye and optic nerve. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and hungtingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as of transferrin receptor (TFRC/TfR); regulates Rab8 recruitnment to tubules emanating from the endocytic recycling compartment. Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52. May constitute a cellular target for adenovirus E3 14.7, an inhibitor of TNF-alpha functions, thereby affecting cell death.. | |
Protein Sequence | MSHQPLSCLTEKGDSPCETPGNGPSNMVHPSLDTFTPEELLQQMKELLVENHQLKEAMKLNNQAMKGRFEELSAWTEKQKEERLLFEMQSKEVKERLKALTHENERLKEELGKFKEKSEKPLEDLTGGYRYPRALEEEVEKLKTQVEQEVEHLKIQVMRLRAEKADLLGIVSELQLKLNSGGSSEDSFVEIRMTEGETEGAMKEMKNCPTPTRTDPISLSNCTEDARSCAEFEELTVSQLLLCLREGNQKVERLEVALREAKERISDFEKKANGHSSTEKQTARRADREKEDKGQESVGSEVETLSIQVTSLFKELQEAHTKLSEAELMKKRLQEKCQALERKNSATPSELNEKQELVYSNKKLELQVESMRSEIKMEQAKTEEEKSRLATLQATHNKLLQEHNKALKTIEELTKQQAEKVDKMLLQELSEKLELAEQALASKQLQMDEMKQTLAKQEEDLETMAVLRAQMEVYCSDFHAERAAREKIHEEKEQLALQLAILLKENNDIEEGGSRQSLMEMQCRHGARTSDSDQQTYLFQRGAEDRSWQHGQQPRSIPIHSCPKCGEVLPDIDTLQIHVMDCII | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MSHQPLSCLTEKGD -CCCCCCCCCCCCCC | 17.48 | 28066266 | |
10 | Phosphorylation | HQPLSCLTEKGDSPC CCCCCCCCCCCCCCC | 39.72 | 28066266 | |
172 | Phosphorylation | ADLLGIVSELQLKLN HHHHHHHHHEEHHHC | 30.57 | 18779572 | |
180 | Phosphorylation | ELQLKLNSGGSSEDS HEEHHHCCCCCCCCC | 55.77 | 26239621 | |
183 | Phosphorylation | LKLNSGGSSEDSFVE HHHCCCCCCCCCCEE | 33.80 | 26239621 | |
184 | Phosphorylation | KLNSGGSSEDSFVEI HHCCCCCCCCCCEEE | 49.01 | 27742792 | |
187 | Phosphorylation | SGGSSEDSFVEIRMT CCCCCCCCCEEEEEC | 27.43 | 25521595 | |
210 | Phosphorylation | KEMKNCPTPTRTDPI HHHCCCCCCCCCCCC | 39.22 | 25521595 | |
212 | Phosphorylation | MKNCPTPTRTDPISL HCCCCCCCCCCCCCC | 48.99 | 24453211 | |
214 | Phosphorylation | NCPTPTRTDPISLSN CCCCCCCCCCCCCCC | 48.91 | 25263469 | |
218 | Phosphorylation | PTRTDPISLSNCTED CCCCCCCCCCCCCCC | 31.00 | 25521595 | |
220 | Phosphorylation | RTDPISLSNCTEDAR CCCCCCCCCCCCCHH | 24.06 | 24453211 | |
223 | Phosphorylation | PISLSNCTEDARSCA CCCCCCCCCCHHHCH | 40.94 | 27742792 | |
250 | Ubiquitination | CLREGNQKVERLEVA HHHHCCHHHHHHHHH | 50.49 | 27667366 | |
294 | Ubiquitination | DREKEDKGQESVGSE HHHHHHHCCCCCHHH | 49.13 | 27667366 | |
297 | Phosphorylation | KEDKGQESVGSEVET HHHHCCCCCHHHHHH | 24.72 | 30352176 | |
345 | Phosphorylation | QALERKNSATPSELN HHHHHCCCCCHHHHH | 36.23 | 27742792 | |
347 | Phosphorylation | LERKNSATPSELNEK HHHCCCCCHHHHHHH | 27.45 | 22324799 | |
349 | Phosphorylation | RKNSATPSELNEKQE HCCCCCHHHHHHHHH | 50.81 | 18846507 | |
443 | Ubiquitination | AEQALASKQLQMDEM HHHHHHHHHHCHHHH | 49.79 | 22790023 | |
451 | Ubiquitination | QLQMDEMKQTLAKQE HHCHHHHHHHHHHHH | 37.78 | 22790023 | |
504 | Ubiquitination | LQLAILLKENNDIEE HHHHHHHHHCCCCCC | 55.75 | - | |
514 | Phosphorylation | NDIEEGGSRQSLMEM CCCCCCCCHHHHHHH | 37.69 | 23684622 | |
517 | Phosphorylation | EEGGSRQSLMEMQCR CCCCCHHHHHHHHCC | 28.68 | - | |
529 | Phosphorylation | QCRHGARTSDSDQQT HCCCCCCCCCHHHHH | 36.03 | 27742792 | |
530 | Phosphorylation | CRHGARTSDSDQQTY CCCCCCCCCHHHHHH | 29.57 | 27087446 | |
532 | Phosphorylation | HGARTSDSDQQTYLF CCCCCCCHHHHHHHH | 36.77 | 26745281 | |
536 | Phosphorylation | TSDSDQQTYLFQRGA CCCHHHHHHHHHCCC | 19.29 | 23984901 | |
547 | Phosphorylation | QRGAEDRSWQHGQQP HCCCCCCCCCCCCCC | 43.33 | 29899451 | |
556 | Phosphorylation | QHGQQPRSIPIHSCP CCCCCCCCCCCCCCC | 39.12 | 23684622 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
187 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OPTN_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OPTN_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
OPTN_MOUSE | Optn | physical | 24983867 | |
HACE1_MOUSE | Hace1 | physical | 25026213 | |
SQSTM_MOUSE | Sqstm1 | physical | 25026213 | |
SEM4A_MOUSE | Sema4a | physical | 22465952 | |
RB11A_MOUSE | Rab11a | physical | 22465952 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187; THR-210 ANDSER-218, AND MASS SPECTROMETRY. |